Yüklüyor......
SABCS 2016: systemic therapy for metastatic breast cancer
At the 2016 San Antonio Breast Cancer Symposium, several interesting phase II and phase III studies investigating systemic therapies for metastatic breast cancer were presented. The PrEGOC 0102 trial demonstrated that the combination of fulvestrant plus everolimus is safe and effective and could be...
Kaydedildi:
| Yayımlandı: | Memo |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Springer Vienna
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5493725/ https://ncbi.nlm.nih.gov/pubmed/28725277 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12254-017-0326-4 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|